Structure and Function of NMDA Receptors
NMDA 受体的结构和功能
基本信息
- 批准号:9248017
- 负责人:
- 金额:$ 12.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-30 至 2019-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAgonistAlzheimer&aposs DiseaseBindingC-terminalCationsCellsChemicalsCommunicationComplementComplexDataDiseaseElectrophysiology (science)ElectrostaticsExtracellular DomainFamilyFoundationsGlutamate ReceptorGlutamatesGlycineImageInvestigationIschemic StrokeLearningLengthLigand Binding DomainMapsMeasurementMediatingMediator of activation proteinMemoryMolecular ConformationMotionN-Methyl-D-Aspartate ReceptorsN-MethylaspartateNMDA receptor A1NeuraxisParkinson DiseasePathway interactionsPhysiological ProcessesProteinsPublishingRoentgen RaysRoleSchizophreniaSeizuresSignal PathwaySignal TransductionStrokeStructureSulfhydryl CompoundsSynaptic TransmissionTimeTranslatingcrosslinkdimerglutamatergic signalinginhibitor/antagonistinsightluminescence resonance energy transfermillisecondmolecular dynamicsmutantnervous system disorderpainful neuropathypublic health relevancereceptorreceptor functionsingle-molecule FRETtransmission process
项目摘要
DESCRIPTION (provided by applicant): N-methyl D-aspartate receptors are a subtype of glutamate receptors that mediate excitatory signal transmission in the mammalian central nervous system. Their primary function involves converting the chemical signal into an electrical signal, i.e. glutamate binding to an extracellular domain in the receptor triggers the formation of
cation permeable transmembrane channels in the receptor. Given the importance of these receptors in mediating a number of physiological processes and the need to modulate their function in disease states, the primary questions are how does the agonist activate the protein and how can this mechanism be modulated. The NMDA receptors are modulator in structure consisting of an amino terminal domain, agonist binding domain, channel segments and the C-terminal domains. Here we propose to study the communication between the domains and their role in dictating activation and allosteric modulation. Specifically we will investigate the role o the interactions between GluN1 agonist binding domain with the GluN2 subunit in controlling agonist binding domain dynamics and extent of activation (specific aim 1) using a combination of luminescence resonance energy transfer, smFRET, and electrophysiology. We will also investigate the pathway for allosteric modulation by establishing the conformational changes starting at the amino terminal domain through the agonist binding domain and study the changes in dynamics in the extracellular domains during the allosteric modulation (specific aim 2). The spectroscopic investigations will be complemented by electrophysiological measurements investigating the changes in function induced by alterations at the interface between the domains. These functional and structural investigations will provide a comprehensive understanding of the conformational pathway as well as role of dynamics in activation and allosteric modulation in NMDA receptor function.
项目成果
期刊论文数量(17)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Super-resolution mbPAINT for optical localization of single-stranded DNA.
- DOI:10.1021/am403984k
- 发表时间:2013-10-09
- 期刊:
- 影响因子:9.5
- 作者:Chen, Jixin;Bremauntz, Alberto;Kisley, Lydia;Shuang, Bo;Landes, Christy F.
- 通讯作者:Landes, Christy F.
Molecular approaches to chromatography using single molecule spectroscopy.
- DOI:10.1021/ac5039225
- 发表时间:2015-01-06
- 期刊:
- 影响因子:7.4
- 作者:Kisley, Lydia;Landes, Christy F.
- 通讯作者:Landes, Christy F.
High ionic strength narrows the population of sites participating in protein ion-exchange adsorption: a single-molecule study.
高离子强度缩小了参与蛋白质离子交换吸附的位点数量:单分子研究。
- DOI:10.1016/j.chroma.2014.03.075
- 发表时间:2014
- 期刊:
- 影响因子:0
- 作者:Kisley,Lydia;Chen,Jixin;Mansur,AndreaP;Dominguez-Medina,Sergio;Kulla,Eliona;Kang,MarciK;Shuang,Bo;Kourentzi,Katerina;Poongavanam,Mohan-Vivekanandan;Dhamane,Sagar;Willson,RichardC;Landes,ChristyF
- 通讯作者:Landes,ChristyF
Fluorescence correlation spectroscopy study of protein transport and dynamic interactions with clustered-charge peptide adsorbents.
- DOI:10.1002/jmr.2206
- 发表时间:2012-08
- 期刊:
- 影响因子:2.7
- 作者:Daniels, Charlisa R.;Kisley, Lydia;Kim, Hannah;Chen, Wen-Hsiang;Poongavanam, Mohan-Vivekanandan;Reznik, Carmen;Kourentzi, Katerina;Willson, Richard C.;Landes, Christy F.
- 通讯作者:Landes, Christy F.
Stargazin promotes closure of the AMPA receptor ligand-binding domain.
- DOI:10.1085/jgp.201411287
- 发表时间:2014-12
- 期刊:
- 影响因子:0
- 作者:MacLean DM;Ramaswamy SS;Du M;Howe JR;Jayaraman V
- 通讯作者:Jayaraman V
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Vasanthi Jayaraman其他文献
Vasanthi Jayaraman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Vasanthi Jayaraman', 18)}}的其他基金
Vibrational Spectroscopic Investigations of Glutamate Receptor
谷氨酸受体的振动光谱研究
- 批准号:
7600442 - 财政年份:2006
- 资助金额:
$ 12.5万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 12.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 12.5万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 12.5万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 12.5万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 12.5万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 12.5万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 12.5万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 12.5万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 12.5万 - 项目类别:
Fentanyl Addiction: Individual Differences, Neural Circuitry, and Treatment with a GLP-1 Receptor Agonist
芬太尼成瘾:个体差异、神经回路和 GLP-1 受体激动剂治疗
- 批准号:
10534864 - 财政年份:2023
- 资助金额:
$ 12.5万 - 项目类别:














{{item.name}}会员




